Thrombomodulin Influences the Survival of Patients with Non-Metastatic Colorectal Cancer through Epithelial-To-Mesenchymal Transition (EMT).

Thrombomodulin Influences the Survival of Patients with Non-Metastatic Colorectal Cancer through Epithelial-To-Mesenchymal Transition (EMT).

Treatment resistance and metastasis are the major causes of death among patients with colorectal cancer (CRC). Approximately 20% of surgically treated patients ultimately develop metastases during the follow-up period. Currently, the TNM system is the only available prognostic test. Therefore, the i...

Full description

Bibliographic Details
Main Authors: Yu-Jia Chang, Ya-Wen Cheng, Ruo-Kai Lin, Chi-Chou Huang, William Tzu-Liang Chen, Tao-Wei Ke, Po-Li Wei
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4981396?pdf=render

Internet

http://europepmc.org/articles/PMC4981396?pdf=render

Similar Items